Hollywood will be getting a new chief lobbyist in Washington.
Former Democratic Senator Chris Dodd, who has been chairman and CEO of the Motion Picture Association of America for the past six years, will step down by the end of the year, the MPAA said Friday.
The MPAA is the primary Washington organization representing major studios. It spent $2.6 million lobbying last year, according to the Center for Responsive Politics.
Dodd spent 30 years in the Senate and served as chairman of the powerful Senate Banking Committee. He announced his retirement in 2010.
Dodd’s successor will be Charles Rivkin, who most recently served as U.S. assistant secretary of state for economic and business affairs from 2014 to 2017. He also spent two decades in the entertainment business, including time as CEO of The Jim Henson Company, which is best known for the Muppets franchise.
Rivkin will join the MPAA on September 5. The trade group says he and Dodd will “work together to complete the transition by the beginning of next year.”
good investment stocks: Manitowoc Company, Inc. (The)(MTW)
Advisors’ Opinion:
- [By Ben Levisohn]
With a neutral sector rating, we are working on evaluating risks to negative calls, and identifying potential value opportunities. Last week we noted more work might be worthwhile on Wabco Holdings (WBC), Terex, Manitowoc (MTW), and Caterpillar, two of those names have rallied for other reasons but the attractive price made the upside/downside skew up. We remain positive (OW) on Allison Transmission Holdings (ALSN) & United Rentals. Our and consensus 2017Allison Transmission Holdings estimates have fallen by 2% vs. ~15% for the group, while the shares are down 10% since launch. We continue to see United Rentals as the best value in our group…
good investment stocks: Suzuki Motor Corporation (SZKMY)
Advisors’ Opinion:
- [By SEEKINGALPHA.COM]
Elon has plans for a Gigafactory 3 somewhere in the US unlike the Gigafactory in Europe. If Tesla can get just two Gigafactories built, it will have the batteries at least to produce vehicles at about the same scale as Suzuki (OTCPK:SZKMY) (Suzuki made about 3mm autos in 2015). In fact, Tesla hopes to have the Gigafactory running flat out by 2020, supplying 3X the number of batteries it needs unless it can ramp production into 2020 further. These batteries will be used on the Tesla Power Walls and other power containment devices it has in its pipeline, but it sure seems that Tesla can ramp its auto production past the 500k units per year in 2019 and 2020. At the very least, it will likely have the batteries to do so.
good investment stocks: Cleveland BioLabs, Inc.(CBLI)
Advisors’ Opinion:
- [By Alex McGuire]
As a service to our readers, the following list provides the 10 top pharmaceutical stocks to watch this month (May 2017), including the biggest gainers from April…
Pharmaceutical Stock Current Share Price April 2017 Gain
Cleveland BioLabs Inc. (Nasdaq: CBLI) $3.62 +120.6%
Nexvet Biopharma Plc. (Nasdaq: NVET) $6.61 +69.7%
Motif Bio Plc. (Nasdaq ADR: MTFB) $10.10 +68.2%
Axovant Sciences Ltd. (NYSE: AXON) $24.43 +62.3%
Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) $5.49 +46.7%
Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) $8.67 +44.9%
Akebia Therapeutics Inc. (Nasdaq: AKBA) $13.07 +43.3%
Akorn Inc. (Nasdaq: AKRX) $33.28 +38.9%
Rockwell Medical Inc. (Nasdaq: RMTI) $8.78 +37.4%
Akari Therapeutics Plc. (Nasdaq ADR: AKTX) $15.02 +35.4%
The best-performing pharma stock of the month – Cleveland BioLabs Inc. – surged 120.6% to $3.53 a share by April 28. That crushed both the Nasdaq Biotech Index’s 1.5% gain and the Dow Jones’ 1.3% rise over the same period.
- [By Lisa Levin]
In trading on Tuesday, healthcare shares fell by 0.98 percent. Meanwhile, top losers in the sector included Cleveland BioLabs, Inc. (NASDAQ: CBLI), down 25 percent, and Infinity Pharmaceuticals Inc. (NASDAQ: INFI), down 8 percent.
- [By Alex McGuire]
You see, penny stocks are attractive because they can offer double-digit or even triple-digit returns in a very short time. For example, Cleveland BioLabs Inc. (Nasdaq: CBLI) skyrocketed from $1.56 at the Thursday, April 13, close to $5.10 on Wednesday, April 19. That’s a stunning 227% return in just three sessions (the markets were closed that Friday).
good investment stocks: BioLineRx Ltd.(BLRX)
Advisors’ Opinion:
- [By Jim Robertson]
On Friday, our Under the Radar Moversnewsletter suggested small cap clinical-stage biopharmaceutical stockBioline RX Ltd (NASDAQ: BLRX) as a speculative buy:
good investment stocks: Berkshire Hathaway Inc.(BRK.A)
Advisors’ Opinion:
- [By Ashley Moore]
At $257,200.00 a share, investing in Berkshire Hathaway Inc. (NYSE: BRK.A) is simply not an option for most retail investors like us. But the nearly 50 other “Warren Buffett stocks” that Berkshire invests in come at a much lower price point.
- [By Sarfaraz Khan]
Shares of Warren Buffett-ledBerkshire Hathaway (NYSE:BRK.A)(NYSE:BRK.B)delivered a blowout performance in 2016 by easily beating the S&P 500 (INDX:SPAL) and Dow Jones Industrial Average (INDX:INDU) and ending the year with a market cap of almost $400 billion for the first time in its history. And I believe the good times will continue in 2017.
- [By WWW.THESTREET.COM]
Warren Buffett’s Berkshire Hathaway (BRK.A) (BRK.B) was upgraded to a “stable” rating outlook at S&P (SPGI) from a “watch negative” outlook on Tuesday.
- [By WWW.THESTREET.COM]
The Berkshire Hathaway (BRK.A) CEO, 86, famously avoided tech stocks for decades, saying, “If there’s lots of technology, we won’t understand it.” However, Berkshire started buying shares of Apple in mid-2016 and ended the year with about 59 million shares in the tech company. In January, Berkshire nearly doubled that stake to 133 million shares. The increased stake gave Berkshire about 2.5% of Apple’s outstanding shares.
good investment stocks: Compass Minerals Intl Inc(CMP)
Advisors’ Opinion:
- [By Monica Gerson]
Compass Minerals International, Inc. (NYSE: CMP) is projected to post its quarterly earnings at $1.33 per share on revenue of $347.03 million.
MKS Instruments, Inc. (NASDAQ: MKSI) is estimated to post its quarterly earnings at $0.33 per share on revenue of $177.19 million.
